Showing results (181-190 of 225) with videos related to
Sort By:
Pageof 23
Neurobiology of Aging|August 6, 2017
CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patientsTobias Skillbäck, Louise Delsing, Jane Synnergren, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 7, 2025
Cholinergic system in patients with chronic kidney disease: cognitive and renal implicationsHong Xu, Maria Eriksdotter, Gaye Hafez, et al.Brain : a Journal of Neurology|July 3, 2015
Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementiaTobias Skillbäck, Bahman Y Farahmand, Christoffer Rosén, et al.Neurology|October 8, 2017
Thrombolysis in acute ischemic stroke in patients with dementia: A Swedish registry studyEva Zupanic, Mia von Euler, Ingemar Kåreholt, et al.Journal of Alzheimer'S Disease : JAD|March 14, 2013
Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markersErik Hjorth, Mingqin Zhu, Veronica Cortés Toro, et al.Journal of Alzheimer'S Disease : JAD|October 9, 2010
Higher cathepsin B levels in plasma in Alzheimer's disease compared to healthy controlsJohan Sundelöf, Johan Sundström, Oskar Hansson, et al.Journal of Alzheimer'S Disease : JAD|June 18, 2010
Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controlsJohan Sundelöf, Johan Sundström, Oskar Hansson, et al.Journal of Alzheimer'S Disease : JAD|January 8, 2025
Medications and cognitive decline in Alzheimer's disease: Cohort cluster analysis of 15,428 patientsPol Grau-Jurado, Shayan Mostafaei, Hong Xu, et al.Journal of Oral Microbiology|February 27, 2023
Subgingival microbiome at different levels of cognitionNele Fogelholm, Jaakko Leskelä, Muhammed Manzoor, et al.Journal of Alzheimer'S Disease : JAD|August 23, 2021
Effects of Peroral Omega-3 Fatty Acid Supplementation on Cerebrospinal Fluid Biomarkers in Patients with Alzheimer's Disease: A Randomized Controlled Trial-The OmegAD StudyAvin Tofiq, Henrik Zetterberg, Kaj Blennow, et al.Pageof 23